Penegra

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Penegra

Penegra is a synthetic compound manufactured as a tablet for oral preparation, whose identity is defined by its active pharmaceutical ingredient, Sildenafil. The primary general purpose of this medication is to support the vascular function required for addressing Erectile Dysfunction (ED) in adult men.


Quick Facts

Property Description
Active ingredient Sildenafil
Form Tablet (Oral preparation)
Pharmacological class Phosphodiesterase type 5 (PDE5) inhibitor
General purpose Supports function in Erectile Dysfunction
Origin Synthetic compound

What Defines Penegra: Composition and Classification

Penegra is a trade name for a medicinal preparation containing the core active ingredient Sildenafil, a substance that belongs to the Phosphodiesterase type 5 (PDE5) inhibitor pharmacological class. The preparation is a single-ingredient product, typically utilizing Sildenafil citrate, which is the specific salt form of the molecule used in its manufacture. Sildenafil's classification as a PDE5 inhibitor facilitates the body's natural response to sexual arousal. This scientific classification is crucial because it identifies the drug's mechanism as selectively blocking the PDE5 enzyme, a key target in vascular smooth muscle. The active ingredient, Sildenafil, is a complex synthetic compound developed entirely through chemical synthesis, a property recognized for its controlled consistency in formulation.


Penegra’s Form, Origin, and Regulatory Status

The physical definition of Penegra is an oral drug, supplied in its standard compressed tablet form. The drug is designed for the oral route of administration, where it is swallowed to allow for systemic absorption of the active ingredient through the gastrointestinal tract. Unlike herbal or naturally derived substances, this medication's function relies solely on its engineered synthetic chemical structure. The mechanism of PDE5 inhibitors enhances the effects of nitric oxide, leading to vasodilation and improved blood flow. This fact confirms that the medication’s effect is achieved through enhancing an existing physiological signal. Penegra is distinguished by its specific marketing focus as a prescription medication for adult men, reflecting the necessity for authorized medical oversight.


General Purpose of the Sildenafil Preparation

The overall purpose of this Sildenafil preparation is to enhance a specific physiological process related to blood flow. By functioning as a PDE5 inhibitor, the drug facilitates the smooth muscle relaxation and subsequent vasodilation within targeted tissues. This enhanced vascular response is the underlying factor that supports the primary general purpose of the drug: facilitating the physical function required for sexual activity in adult men who are dealing with Erectile Dysfunction (ED), such as restoring the ability to achieve or sustain an erection. This single-ingredient focus ensures a clear mechanism dedicated to this vascular response.

Regulatory References

  1. Sildenafil EPAR Summary

What side effects are possible with Penegra?

Possible Side Effects and Safety Information

The safety profile of Penegra, which contains the active ingredient Sildenafil, is based on official regulatory classifications, separating commonly reported effects from rare but serious events. Adverse reactions are grouped by physiological systems (System-Organ Classes) and categorized by their frequency, according to regulatory documents such as the FDA Prescribing Information and the EMA Summary of Product Characteristics (SmPC).

Classification Examples of Officially Documented Adverse Reactions
Common (ge 1/100 to <1/10) Headache, flushing, dizziness, dyspepsia (indigestion), and abnormal vision (such as color tinge or blurred vision).
Uncommon to Rare Rhinitis, rash, syncope, hypertension, hypotension, epistaxis (nosebleed), and serious events.

Serious adverse reactions are reported in post-marketing surveillance and warnings. These include Priapism (a prolonged erection lasting over four hours), Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) leading to vision loss, and sudden decrease or loss of hearing. Serious cardiovascular events, such as myocardial infarction or stroke, have also been reported in temporal association with use.

Specific safety restrictions are defined in official labeling. The medication is contraindicated for individuals using any form of organic nitrates or nitric oxide donors due to the risk of severe, life-threatening hypotension. Caution is also advised for patients with certain anatomical deformations of the penis (e.g., Peyronie's disease), severe hepatic impairment, or pre-existing low blood pressure.

Overdose and Emergency Response

When exposure to Sildenafil (Penegra) exceeds recommended levels, the official regulatory profile describes manifestations consistent with an exaggeration of the drug's vasodilatory effects. Documented signs of overexposure include profound hypotension (decreased blood pressure), syncope, abnormal vision (e.g., changes in color perception), increased severity of headache, and flushing.

A severe and time-critical complication is priapism, defined as an erection lasting for more than four hours. This condition requires immediate medical attention to prevent irreversible penile tissue damage and potential permanent loss of potency, as explicitly stated in prescribing information. Urgent help must also be sought if sudden vision loss or sudden hearing decrease occurs.

Official Management and Considerations

Management for overdosage is symptomatic and supportive. The regulatory information notes that no specific antidote is known for Sildenafil. Furthermore, due to the active ingredient's high protein binding, renal dialysis is not expected to accelerate clearance.

  • Mandated Action: Seek immediate medical attention or call the nearest hospital emergency room right away for accidental overexposure.
  • Population Notes: Patients with severe hepatic or renal impairment, and those who are elderly, are recognized as having reduced drug clearance, which may increase systemic exposure following overdosage.

Therapeutic Uses of Penegra

Quick Facts

  • Primary Use: Supports the management of erectile dysfunction (ED).
  • Therapeutic Action: Facilitates erectile function in adult men during sexual stimulation.

Penegra, which contains the active ingredient sildenafil, is indicated for the medical management of erectile dysfunction (ED) in adult males. This condition relates to an inability to achieve or sustain an erection appropriate for satisfactory sexual activity.

The use of this medication is intended to assist in restoring impaired erectile function. It works by addressing the underlying physiological challenges that impede blood circulation necessary for an erection to occur in response to sexual arousal. It is important to understand that the treatment assists function only when sexual stimulation is present; it does not generate or increase sexual desire on its own.

Additionally, sildenafil is utilized in certain formulations to support the treatment of pulmonary arterial hypertension (PAH). This condition involves elevated blood pressure in the arteries of the lungs. For patients with PAH, the medication aims to support exercise capacity and may contribute to delaying clinical worsening.

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility for Penegra

Penegra, which contains sildenafil, is officially labeled for use only in adult men for the treatment of Erectile Dysfunction (ED). Regulatory documents define strict constraints for eligibility, primarily through absolute contraindications and conditional use restrictions.

Absolute Contraindications (Must Not Use)

Population/Condition Restriction Basis
Patients taking Nitrates or Nitric Oxide Donors Risk of severe, life-threatening hypotension.
Patients taking Guanylate Cyclase stimulators (e.g., riociguat) Risk of symptomatic hypotension.
Recent stroke, MI, or life-threatening arrhythmia Sexual activity is medically inadvisable (within 6 months).
History of Non-arteritic anterior ischaemic optic neuropathy (NAION) Risk of vision loss recurrence.
Known hypersensitivity to sildenafil or excipients Standard regulatory exclusion.

Conditional Use and Age Limitations

  • Use is not recommended for the ED indication in pediatric patients (under 18 years of age).
  • Patients with severe renal impairment or severe hepatic impairment may require consideration for a lower initial starting dose than healthy adults, as stated in the product labeling.
  • Caution is advised for patients with certain anatomical penile deformations (e.g., Peyronie's disease) or conditions predisposing to priapism (e.g., sickle cell disease).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Penegra's official interaction profile is defined by pharmacodynamic reinforcement and pharmacokinetic exposure modification, as documented in government regulatory sources.

Interaction Classifications (High-Level)

Classification Official Regulatory Documentation
Interaction Severity Contraindicated (e.g., Nitrates, Riociguat); Exposure-Modifying (e.g., Ritonavir, Ketoconazole); Potentially Hypotensive (e.g., Alpha-blockers).
Regulatory Basis Based on data compiled in official regulatory documents from authorities including the FDA and EMA.

Official Interaction Statements

  • Absolute Prohibition: Co-administration with all forms of organic nitrates or nitric oxide donors (including recreational alkyl nitrites) is contraindicated due to severe, additive blood pressure lowering. The combination with Guanylate Cyclase (GC) Stimulators (e.g., Riociguat) is also prohibited.
  • Exposure-Increasing Interactions: Medicines that are potent CYP3A4 inhibitors (e.g., Ritonavir, Ketoconazole) significantly increase Sildenafil's plasma exposure due to reduced metabolic clearance.
  • Pharmacodynamic Risk: Concomitant use with alpha-blockers (e.g., Doxazosin) or other anti-hypertensives may result in additive blood pressure lowering effects.
  • Timing Restriction: When co-administering with Ritonavir, regulatory information specifies that the maximum single dose must not exceed 25 mg in a 48-hour period.
  • Substance Interactions: Consumption of a high-fat meal may delay the time to maximal plasma concentration. Grapefruit juice may modestly increase plasma levels.

The interaction structure establishes clear guidelines for combination use, dictated by the metabolic fate and the vascular activity of the medicine.

Mechanism of Action

Selective Inhibition of the PDE5 Enzyme

The drug's mechanism involves competitive inhibition of the Phosphodiesterase type 5 (PDE5) enzyme. This interaction prevents PDE5 from performing its natural function, the enzymatic breakdown of the key signaling molecule, cyclic Guanosine Monophosphate (cGMP), primarily in the smooth muscle of the penile vasculature.

️ Enhancement of the NO-cGMP Pathway

The molecule enhances the activity of the natural Nitric Oxide (NO)-cGMP signaling pathway that is initiated by sexual arousal. By stopping the degradation of cGMP, Sildenafil sustains the molecular signal for smooth muscle relaxation, an action dependent on the prior release of NO.

Consequence: System-Level Vascular Relaxation

This sustained elevation of cGMP directly causes smooth muscle relaxation in the cavernosal arteries, leading to vasodilation. The resulting increase in local blood flow and tissue engorgement is the physical consequence of the vascular relaxation, while strictly being constrained by the prerequisite of sexual stimulation.

Dosage and Administration Information

Official Administration Guidelines for Sildenafil

The general principles of how sildenafil, the active ingredient in Penegra, is used follow distinct administration patterns. The standard form for addressing Erectile Dysfunction (ED) is an oral tablet. While this section focuses on the intermittent oral use associated with ED, sildenafil is also available as an oral suspension and an intravenous injection for the treatment of Pulmonary Arterial Hypertension (PAH).

Dosage and Frequency for Erectile Dysfunction

Category Official Instruction
Route of Administration Oral
Starting Dose Typically 50 mg
Maintenance Range 25 mg to 100 mg
Maximum Frequency Once per day

The medication is used on an as-needed basis, taken approximately one hour before planned sexual activity. The window for administration extends from 30 minutes up to 4 hours prior to activity. The decision to adjust the dose within the 25 mg to 100 mg range is based on the initial response and tolerability.

Contextual and Population-Specific Use

A key factor in administration is the patient’s intake condition. Taking the tablet with a high-fat meal may result in a delayed onset of activity. Furthermore, standard protocols indicate that a starting dose of 25 mg should be considered for specific populations, including older adults (65 years and over), as well as patients who have severe renal impairment or hepatic impairment. This protocol is necessary due to expected changes in how the body processes the medication in these groups.

Recent Clinical Evidence

Summary of Efficacy Trials

Penegra, which contains the active ingredient sildenafil, has been extensively evaluated for the treatment of erectile dysfunction (ED) in men across a wide range of patient profiles. Large-scale randomized, double-blind, placebo-controlled clinical studies have consistently investigated the drug's effect on erectile function, as measured by standardized patient questionnaires like the International Index of Erectile Function (IIEF).

Research has explored whether the compound improved erectile function across broad patient populations, including those with associated health conditions such as diabetes mellitus, hypertension, and post-radical prostatectomy ED. Findings consistently showed that sildenafil demonstrated an improved ability for men to achieve and maintain an erection compared to placebo across these varied subgroups.


Tolerability and Long-Term Use

Toxicity studies and clinical trials have evaluated the compound's tolerability. Most reported adverse events, such as headache and flushing, were generally mild and temporary. Discontinuation rates due to treatment-related side effects have historically been low across trials.

Long-term extension studies, some lasting up to four years, have assessed the drug's safety and effectiveness over extended periods. These data suggest that the compound's effectiveness is maintained with long-term use, and no significant loss of tolerability or increased rate of adverse events was observed over the duration of these studies. This long-term research is important given that ED is often a chronic condition.

Key Studies & References

  1. Efficacy and Safety of Oral Sildenafil in the Treatment of Erectile Dysfunction: A Double-Blind, Placebo-Controlled Study

Frequently Asked Questions (FAQ)

Common questions about Penegra (FAQ)

Q: Can women use Penegra?

Official documents define the use of the active ingredient, sildenafil, for the treatment of Erectile Dysfunction (ED) only in adult men. The standard form of the drug is not generally indicated or approved for use by women for this purpose.

Q: Is Penegra safe for older men?

Official labeling addresses the use of this medicine in older adults. It specifies that a lower starting dose should be considered for men 65 years and over due to expected changes in how the body processes the medication. This protocol is defined in the regulatory information.

Q: Does Penegra interact with alcohol?

While regulatory labels do not prohibit alcohol entirely, authoritative medical information indicates that drinking large amounts of alcohol may make it more difficult to get an erection. This can reduce the potential benefit of the medication.

Q: Can I take Penegra if I have high blood pressure?

This medication has properties that cause temporary decreases in blood pressure. Caution is officially advised for individuals who are currently taking antihypertensive therapy (medication for high blood pressure). This is due to the potential for an additive blood pressure lowering effect.

Q: Are there any foods I should avoid when taking Penegra?

Official product information does not list foods as absolutely prohibited. However, consuming a high-fat meal may delay the time it takes for the drug to start working. Additionally, grapefruit juice has been noted to modestly increase the level of the active ingredient in the bloodstream.

Q: Does taking Penegra with food change how it works?

Yes, taking the tablet with a high-fat meal is documented to change the absorption rate. This can result in a delayed onset of activity, meaning it may take longer than expected for the medication to begin working.

Q: Does Penegra affect fertility?

The official product labeling is focused on the treatment of Erectile Dysfunction. Nonclinical toxicology studies have been conducted to look at the potential for fertility impairment, but comprehensive details on effects on human fertility are not a primary component of the standard prescribing information.

Q: What is the risk of a prolonged erection with Penegra?

A prolonged erection lasting over four hours, known as priapism, has been reported in post-marketing experience. Regulatory documents advise seeking prompt medical attention if an erection persists for this duration to prevent potential tissue damage.

Q: How does the research evidence describe the benefits of Penegra?

Clinical trials reviewed by regulatory bodies have consistently shown that the drug assists men in the ability to achieve and maintain an erection suitable for sexual activity. The research compared outcomes in men using the drug versus those using a placebo.

Q: Does Penegra lose its effectiveness over time?

Long-term extension studies, which followed participants for up to four years, have addressed this question. The data from these studies suggested that the compound's effectiveness is maintained with continued long-term use.

Q: Do studies mention long-term safety data for Penegra?

Yes, studies lasting up to four years have been conducted to evaluate the drug's long-term safety. These findings indicated that no significant loss of tolerability or increased rate of adverse events was observed over the duration of the studies.

Q: What is the difference between Penegra and sildenafil?

Sildenafil is the name of the active ingredient within the medicine, which is responsible for its effects. Penegra is a specific trade name or brand name under which the sildenafil preparation is manufactured and marketed.

Q: Is it safe to use Penegra every day?

The medication is officially approved for use on an as-needed basis prior to sexual activity. The maximum recommended dosing frequency defined by regulatory sources for the ED indication is once per day.

Q: What should I do if I miss a dose of Penegra?

As the product is intended for as-needed use, and is not a scheduled daily treatment, official guidance does not include instructions for a 'missed dose.' It is taken only when necessary, about an hour before planned sexual activity.

Q: Is there a generic version of Penegra?

After the original patent expired, other manufacturers were permitted to produce the medicine using the active ingredient. This is referred to as generic sildenafil, and it is regulated for quality and consistency just like the brand-name products.

Q: What happens if I take Penegra and don't need it?

The mechanism of action of the drug requires sexual stimulation to begin working. The medication is only intended to enhance the body's natural response to arousal and has no direct relaxant effect on the penile tissue without this stimulation.

Q: Can I take Penegra if I have diabetes?

Clinical trials for this medicine included men who had associated health conditions, such as diabetes mellitus. The research specifically investigated the drug's effect on erectile function in this particular patient group.

Q: How long has Penegra been available?

The active ingredient, sildenafil, received its initial marketing authorization from the US Food and Drug Administration (FDA) for the treatment of erectile dysfunction in 1998. Other regional approvals followed a similar timeline.

Q: What kind of studies have been done on Penegra?

The efficacy and safety of the drug were established through extensive research. These included randomized, double-blind, placebo-controlled clinical studies and long-term extension studies across varied patient populations.

Q: Is Penegra approved by regulatory bodies?

Yes, preparations containing sildenafil have been granted marketing authorization by major government regulatory bodies worldwide, including the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Q: Why do official documents state Penegra is only for a specific condition?

A drug's official indication is based entirely on the specific evidence collected in clinical trials and submitted to regulatory agencies. These agencies only approve the drug for the condition where the benefits have been scientifically demonstrated to outweigh the risks.

Q: Is there a maximum amount of Penegra that can be taken?

Regulatory documents define the standard dose range for the ED indication. The maximum recommended single dose is specified as 100 mg, and the maximum recommended frequency for the ED indication is once per day.

Q: What is the typical timeframe for seeing effects from Penegra?

The drug is generally recommended to be taken approximately one hour before planned sexual activity. Studies indicate that maximum concentrations of the medicine in the bloodstream are typically reached within about one hour.

Q: What are the signs of a serious reaction to Penegra?

Official warnings describe specific serious adverse events. These include a prolonged erection (priapism) lasting more than four hours, sudden loss of vision, or sudden decrease or loss of hearing. The official warnings indicate that prompt medical assistance should be sought if these events occur.

Q: Can Penegra interact with herbal supplements?

Regulatory guidance states that it is not possible to confirm the safety of using herbal remedies and supplements with prescription medications. This is because supplements are not typically tested in the same way as approved prescription drugs.

Q: Is Penegra considered a permanent treatment?

For the treatment of Erectile Dysfunction, the medication is approved for use on an as-needed basis prior to sexual activity. It is not intended to be a continuous scheduled therapy or a cure for the underlying condition.

Q: Can Penegra cause dizziness or lightheadedness?

Dizziness is listed in the official documents as a common adverse reaction. Lightheadedness may occur, particularly in association with the drop in blood pressure that can happen when this medication is used with certain other blood pressure lowering drugs.

Q: What if Penegra doesn't work for me the first time?

Official guidelines state that the dose may be adjusted from the starting dose based on initial response and tolerability, as defined in the product label. The official documents define the range of allowed dose modifications.

Q: Are there different forms of Penegra (e.g., tablet, liquid)?

The active ingredient, sildenafil, is available as an oral tablet for the ED indication. It is also available in forms such as an oral suspension or intravenous injection when prescribed for the treatment of Pulmonary Arterial Hypertension (PAH).

Q: Why is Penegra contraindicated for people taking certain blood pressure medicines?

The medication is absolutely prohibited for individuals taking organic nitrates or nitric oxide donors. This is because combining these substances can cause a severe, additive blood pressure lowering effect that can lead to life-threatening hypotension.

Q: Is Penegra used to treat pulmonary hypertension?

Yes, the active ingredient sildenafil is indicated by regulatory bodies for the treatment of Pulmonary Arterial Hypertension (PAH), which is a condition of high blood pressure in the arteries of the lungs. This use often involves a different dosage and brand name.

Q: Can I take Penegra after a large meal?

Yes, but be aware of the impact on absorption. Regulatory documents show that taking the medication with a large, high-fat meal may result in a delayed onset of activity. This means the time it takes to see the effects could be longer than if it was taken on an empty stomach.

Q: Is there a specific time of day recommended for taking Penegra?

The medication is intended for use as needed, not on a fixed schedule. Official recommendations state that it should be taken approximately one hour before planned sexual activity, within a specified window of time.

How should Penegra be stored and disposed of?

How to Store and Dispose of Penegra

Official regulatory guidelines define specific conditions for storing and disposing of Penegra (sildenafil citrate) to maintain product stability and protect the environment.


Storage Conditions

Penegra tablets must be stored at Controlled Room Temperature, ideally between 20 C and 25 C (68 F and 77 F). The container must be kept tightly closed in a dry place and away from direct sunlight to prevent degradation. It is a mandatory safety requirement to store the medication out of the reach of children. The product must not be used after its labeled expiration date.


Disposal Instructions

Expired or unused Penegra should not be disposed of in household trash or flushed down a toilet or drain. Disposal into sewer systems is prohibited to prevent environmental contamination. The medication must be disposed of in accordance with local requirements, typically utilizing a drug take-back program or an approved pharmaceutical waste disposal method.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Penegra found in:

A-Z Index: